About GNI Group
GNI Group is a company based in Chiba (Japan) founded in 2001. The company has 867 employees as of December 31, 2024. GNI Group has completed 1 acquisition, including Ayumi Pharmaceutical.
- Headquarter Chiba, Japan
- Employees 867 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gni Group Ltd.
-
Annual Revenue
$150.43 M (USD)-9.22as on Dec 31, 2024
-
Net Profit
$7.01 M (USD)-86.43as on Dec 31, 2024
-
EBITDA
$2.78 M (USD)-91.58as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
867
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GNI Group
GNI Group is a publicly listed company on the TSE with ticker symbol 2160 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of GNI Group
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of GNI Group
Detailed funding history for GNI Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GNI Group
GNI Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Ayumi Pharmaceutical.
Investment portfolio details for GNI Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Specialty generic drugs for rheumatism and orthopedics are manufactured.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for GNI Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - GNI Group
Detailed financials for GNI Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gni Group Comparisons
Peer comparison for GNI Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GNI Group
Detailed competitors of GNI Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gni Group
Complete news archive for GNI Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GNI Group
GNI Group was founded in 2001.
GNI Group is headquartered in Chiba, Japan. It is registered at Chiba, Chiba, Japan.
As of Dec 31, 2024, the latest employee count at GNI Group is 867.
Annual revenue of GNI Group is $150.43M as on Dec 31, 2024.
Gni pharma is engaged in the research, development, manufacturing and sales of pharmaceutical drugs and traditional Chinese medicines. The drug development pipeline includes tamibarotene for acute promyelocytic leukemia under preparation for import drug registration; F351 in phase 1 for liver fibrosis and for chronic kidney failure in preclinical stage; F573 for acute chronic liver failure in investigational new drug application stage; and etuary for pulmonary fibrosis (approved), for radiation pneumonitis in phase 2, for diabetic nephropathy in preclinical stage, and connective disease in preclinical stage.
Yes, GNI Group is publicly traded on TSE under the ticker symbol 2160.
GNI Group has made 1 acquisition, including Ayumi Pharmaceutical.
The ticker symbol of GNI Group is 2160 on TSE.